Industry reports
Editor highlights

Factor Ix Market and Forecasts, April 2014

You might be interested in: blood supply, coagulation, natural gas, more »


 
1-10 of 26 reports for Factor Ix

Blood Supply Market in Netherlands

  • Industry report
  • October 2013
  • 2 pages
  • by Corporation

... Manufacture of factor ix antibody royal dsm, the global life sciences and materials sciences company, today announced it has signed an agreement with the sanquin blood supply foundation (sanquin ...

Pharmaceutical Sector in The United States

  • Industry report
  • April 2013
  • 43 pages

... Glyco-pegylation Recombinant factor ix Equivalent potency to recombinant factor ix Better duration of hemostasis after bleeding challenge in mice Half-life prolonged to 93 hours negrier ...

Coagulation Business Brief

  • Industry report
  • August 2012
  • 2 pages

... Viii (chromogenic) Factor viii (clotting) factor ix (chromogenic) factor ix (clotting) Factor x (chromogenic) Factor x (clotting) Factor xi Factor xii Factor xiii Fibrin degradation ...

Coagulation Industry Brief

  • Industry report
  • August 2013
  • 2 pages

... Viii (chromogenic) factor viii (clotting) factor ix (chromogenic) factor ix (clotting) factor x (chromogenic) factor x (clotting) factor xi factor xii factor xiii fibrin degradation ...

Blood Supply Production and Trade Statistics in Netherlands, San Marino and Germany

  • Industry report
  • June 2012
  • 38 pages

... Fraction v fraction v fraction iv fraction ii fraction viii albumin (25 grams) factor viii 200 ius factor ix 275 ius alpha-i antitrypsin (0.25 Grams) atiii polyvalent igiv ...

U.S. Protein Sector Brief

  • Industry report
  • September 2012
  • 7 pages

... Bessos h, bishop jo, et al. Expression of human anti- hemophilic factor ix in the milk of transgenic sheep. Biotechnology (n y) l989;7:487-92. 17. Anson ds, austen deg, brownlee gg. Expression of active ...

Clinical Trial in Europe : Innovation and Technology Trends

  • Industry report
  • June 2012
  • 20 pages

... Derived factor ix products Regulation (ec) no 1901/2006 Paediatric investigational plan needs to be approved by pdco-ema 9 many activities from study design submission to first patient treated ...

The European Pharmaceutical Business

  • Industry report
  • October 2013
  • 34 pages

... Studies - factor ix 3 to 5-fold factor viii 1.5 To 1.6-Fold flora peyvandi the haemophilia community welcome all of these approaches not clear which of these will result in best clinical ...

Coagulation Market in Ireland

  • Industry report
  • May 2012
  • 8 pages

... Coagulation factor vii [iu/ml] 1.09 0.05 0.62-1.65 Coagulation factor viii [iu/ml] 0.80 0.07 0.45-1.68 Coagulation factor ix [iu/ml] 0.88 0.10 0.45-1.48 Coagulation factor x [iu/ml] 0.99 0.05 0 ...

Fruit and Vegetable Market in Taiwan

  • Industry report
  • September 2012
  • 15 pages
  • by Governmental Agency

... A treatment. Similar research is being conducted on transgenic pigs to produce human factor ix. Taiwan has successfully transferred the technology for transgenic pigs with human factor ix gene to a private ...

» Purchase Premium Reports (From $ 125 - $ 2 688)

8 reports for Factor Ix
Prolor Biotech, Inc. (PBTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Prolor Biotech, Inc. (PBTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary PROLOR Biotech, Inc. (Prolor), formerly Modigene Inc., is a development stage biopharmaceutical company. It focuses on developing longer-lasting, proprietary versions of already approved therapeutic ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.